Please assess the completion status of the following clinical trial:

Trial Title: H-29 DELTA Multihole TT Study.

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_ONLY
- Primary Purpose: None
- Time Perspective: RETROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Male or female subjects who underwent a Total Hip Arthroplasty with Delta Multihole TT acetabular cup, as per indications for use, in 2019 onwards~* Age ≥ 18 years old~* Subjects who have signed the written informed consent approved by the reference Ethics Committee (EC)~* Subjects able to comply with the protocol and to perform all scheduled follow-up visits~Exclusion Criteria:~* Male or female subjects who underwent a Total Hip Arthroplasty with Delta Multihole TT acetabular cup, but showed any of the contraindications reported in the Instruction for Use~* Age \< 18 years old~* Any clinically significant pathology based on clinical history that the Investigator feels may affect the study evaluation including, but not limited to:~  1. significant neurological or musculoskeletal disorders or disease that may adversely affect gait and compromise functional recovery.~ 2. neuromuscular or neurosensory deficit which would limit the ability to assess the performance of the device.~ 3. known metabolic disorders leading to progressive bone deterioration.~* Hip replacement on the contralateral side performed within less than one year.~* Female subjects who are pregnant, nursing or planning a pregnancy.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Based on this trial design, predict the completion outcome and termination type (if applicable).